Medical professionals have debated whether removing the thymus of a person with myasthenia gravis is an effective way of treating their disease. A Phase 3 clinical trial seems to have settled the debate. It concludes that the surgery, known as a thymectomy, plus medication is better than medication alone in…
News
ALS and myasthenia gravis have features in common, including an underlying immunological mechanism and alterations in communication junctions between muscle and nerve cells, Chinese researchers report. The Peking Union Medical College team published its study in Frontiers in Neurology. Its title was “Amyotrophic Lateral Sclerosis and Myasthenia Gravis Overlap Syndrome: A…
Alexion Pharmaceuticals has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion to extend the approved indication of Soliris (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) to patients who are anti-acetylcholine receptor (AChR) antibody-positive,…
News
Researchers Gain Insight Into How Myasthenia Gravis Antibodies Destroy Receptor Vital to Movement
University of Southern California researchers have gained insight into how antibodies connected with a disease known as myasthenia gravis destroy a receptor crucial to movement. Their findings may give scientists clues about how to prevent the disease. The study, “Structural insights into the molecular mechanisms of…
Recent Posts
- Does myasthenia gravis really have that much power over me?
- Recovery after MG flares takes many months, even with newer meds: Study
- Severe MG, high corticosteroid dose tied to worse psychological distress
- I’m limiting my news consumption to better manage my health with MG
- New Phase 3 study results support Vyvgart Hytrulo in ocular MG